A citation-based method for searching scientific literature

Hugo Vicente Miranda, Omar M A El-Agnaf, Tiago Fleming Outeiro. Mov Disord 2016
Times Cited: 74







List of co-cited articles
869 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
Hugo Vicente Miranda, Éva M Szego, Luís M A Oliveira, Carlo Breda, Ekrem Darendelioglu, Rita M de Oliveira, Diana G Ferreira, Marcos A Gomes, Ruth Rott, Márcia Oliveira,[...]. Brain 2017
106
22

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
292
16

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
99
16

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
93
14

Increased risk of Parkinson disease with diabetes mellitus in a population-based study.
Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
65
16

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
13

The sour side of neurodegenerative disorders: the effects of protein glycation.
Hugo Vicente Miranda, Tiago Fleming Outeiro. J Pathol 2010
114
12

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
Laura Dunn, George Fg Allen, Adamantios Mamais, Helen Ling, Abi Li, Kate E Duberley, Iain P Hargreaves, Simon Pope, Janice L Holton, Andrew Lees,[...]. Neurobiol Aging 2014
131
12

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
127
12

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
M G Spillantini, R A Crowther, R Jakes, M Hasegawa, M Goedert. Proc Natl Acad Sci U S A 1998
12

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
139
12

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
81
12

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
114
12

Methylglyoxal, the dark side of glycolysis.
Igor Allaman, Mireille Bélanger, Pierre J Magistretti. Front Neurosci 2015
278
10

A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
Bingjie Xie, Fankai Lin, Kaleem Ullah, Lei Peng, Wei Ding, Rongji Dai, Hong Qing, Yulin Deng. Biochem Biophys Res Commun 2015
23
34

Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Esther Dalfó, Manuel Portero-Otín, Victoria Ayala, Anna Martínez, Reinald Pamplona, Isidre Ferrer. J Neuropathol Exp Neurol 2005
175
10

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
169
10

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.
G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini. Free Radic Res 2013
402
10

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
361
10

Shared dysregulated pathways lead to Parkinson's disease and diabetes.
Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
140
10

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
Annekatrin König, Hugo Vicente Miranda, Tiago Fleming Outeiro. J Parkinsons Dis 2018
23
34


Human DJ-1 and its homologs are novel glyoxalases.
Ju-young Lee, Jeeyeon Song, Kyu Kwon, Sumi Jang, Chayeon Kim, Kwanghee Baek, Jeongho Kim, Chankyu Park. Hum Mol Genet 2012
175
9

Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues.
Gilbert Richarme, Mouadh Mihoub, Julien Dairou, Linh Chi Bui, Thibaut Leger, Aazdine Lamouri. J Biol Chem 2015
161
9

Glycation exacerbates the neuronal toxicity of β-amyloid.
X-H Li, L-L Du, X-S Cheng, X Jiang, Y Zhang, B-L Lv, R Liu, J-Z Wang, X-W Zhou. Cell Death Dis 2013
110
9

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
G Münch, H J Lüth, A Wong, T Arendt, E Hirsch, R Ravid, P Riederer. J Chem Neuroanat 2000
160
9

The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process.
Daekyun Lee, Chang Wook Park, Seung R Paik, Kwan Yong Choi. Biochim Biophys Acta 2009
63
11

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
291
9

Role of methylglyoxal in Alzheimer's disease.
Cristina Angeloni, Laura Zambonin, Silvana Hrelia. Biomed Res Int 2014
95
9

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics).
Tomoaki Uchiki, Karen A Weikel, Wangwang Jiao, Fu Shang, Andrea Caceres, Dorota Pawlak, James T Handa, Michael Brownlee, Ram Nagaraj, Allen Taylor. Aging Cell 2012
127
9

Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains.
Yulin Deng, Yongqian Zhang, Yujuan Li, Shengyuan Xiao, Dewei Song, Hong Qing, Qin Li, Ali H Rajput. J Neural Transm (Vienna) 2012
27
25

Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes.
De-Wei Song, Nian Xin, Bing-Jie Xie, Yu-Juan Li, Ling-Yan Meng, Hong-Mei Li, Michael Schläppi, Yu-Lin Deng. Int J Mol Med 2014
19
36

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
108
9

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies.
Lin Lu, Deng-Lei Fu, Hui-Qin Li, Ai-Ju Liu, Ji-Huang Li, Guo-Qing Zheng. PLoS One 2014
73
9

Advanced glycation end-products: a review.
R Singh, A Barden, T Mori, L Beilin. Diabetologia 2001
8

The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.
Angel Herrero-Mendez, Angeles Almeida, Emilio Fernández, Carolina Maestre, Salvador Moncada, Juan P Bolaños. Nat Cell Biol 2009
523
8

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.
Alexander Kurz, Naila Rabbani, Michael Walter, Michael Bonin, Paul Thornalley, Georg Auburger, Suzana Gispert. Cell Mol Life Sci 2011
61
9

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
R Castellani, M A Smith, P L Richey, G Perry. Brain Res 1996
256
8

Age-dependent changes of glyoxalase I expression in human brain.
Björn Kuhla, Katharina Boeck, Hans-Joachim Lüth, Angela Schmidt, Bernd Weigle, Marc Schmitz, Vera Ogunlade, Gerald Münch, Thomas Arendt. Neurobiol Aging 2006
69
8

Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.
Michal Schnaider Beeri, Erin Moshier, James Schmeidler, James Godbold, Jaime Uribarri, Sarah Reddy, Mary Sano, Hillel T Grossman, Weijing Cai, Helen Vlassara,[...]. Mech Ageing Dev 2011
88
8

Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.
Jinlong Li, Danian Liu, Ling Sun, Yunting Lu, Zhongling Zhang. J Neurol Sci 2012
182
8

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Nicolaas I Bohnen, Vikas Kotagal, Martijn L T M Müller, Robert A Koeppe, Peter J H Scott, Roger L Albin, Kirk A Frey, Myria Petrou. Parkinsonism Relat Disord 2014
50
12

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
65
9

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
151
8

Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Nikita Katila, Sunil Bhurtel, Sina Shadfar, Sunil Srivastav, Sabita Neupane, Uttam Ojha, Gil-Saeng Jeong, Dong-Young Choi. Neuropharmacology 2017
87
8


Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
Ruth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, David T Dexter, Liam Smeeth, Ian Douglas. PLoS Med 2015
83
8

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
38
15

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
8

Methylglyoxal can mediate behavioral and neurochemical alterations in rat brain.
Fernanda Hansen, Pablo Pandolfo, Fabiana Galland, Felipe Vasconcelos Torres, Márcio Ferreira Dutra, Cristiane Batassini, Maria Cristina Guerra, Marina Concli Leite, Carlos-Alberto Gonçalves. Physiol Behav 2016
28
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.